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Abstract
Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide. Consider-
ing the World Health Organization recommendation to implement child contact manage-
ment (CCM) for TB, we conducted a mixed-methods systematic review to summarize CCM
implementation, challenges, predictors, and recommendations. We searched the electronic
databases of PubMed/MEDLINE, Scopus, and Web of Science for studies published
between 1996–2017 that reported CCM data from high TB-burden countries. Protocol
details for this systematic review were registered on PROSPERO: International prospective
register of systematic reviews (#CRD42016038105). We formulated a search strategy to
identify all available studies, published in English that specifically targeted a) population:
child contacts (<15 years) exposed to TB in the household from programmatic settings in
high burden countries (HBCs), b) interventions: CCM strategies implemented within the
CCM cascade, c) comparisons: CCM strategies studied and compared in HBCs, and d) out-
comes: monitoring and evaluation of CCM outcomes reported in the literature for each CCM
cascade step. We included any quantitative, qualitative, mixed-methods study design
except for randomized-controlled trials, editorials or commentaries. Thirty-seven studies
were reviewed. Child contact losses varied greatly for screening, isoniazid preventive ther-
apy initiation, and completion. CCM challenges included: infrastructure, knowledge, atti-
tudes, stigma, access, competing priorities, and treatment. CCM recommendations
included: health system strengthening, health education, and improved preventive therapy.
Identified predictors included: index case and clinic characteristics, perceptions of barriers
and risk, costs, and treatment characteristics. CCM lacks standardization resulting in com-
mon challenges and losses throughout the CCM cascade. Prioritization of a CCM-friendly
healthcare environment with improved CCM processes and tools; health education; and
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active, evidence-based strategies can decrease barriers. A focused approach toward every
aspect of the CCM cascade will likely diminish losses throughout the CCM cascade and ulti-
mately decrease TB related morbidity and mortality in children.
Background
Tuberculosis (TB) remains a leading infectious cause of morbidity and mortality worldwide.
In 2015, there were an estimated 10.4 million incident cases of TB and 1.8 million TB deaths.
At least 1.0 million (10%) of these cases were estimated to be in children [1]. Children <15
years contribute approximately 10–20% of disease burden in TB-endemic areas [2]. The risk of
TB disease progression in children is significantly higher than in adults, particularly in chil-
dren <5 years [3, 4]. Additionally, there is increased risk of TB during adolescence [5, 6],
which may result from new infection or progression of latent TB infection to active disease.
Although young children are at great risk of progressing to severe disease and death [4, 7], iso-
niazid preventive therapy (IPT) decreases the progression of TB disease by 59% in this vulnera-
ble population [8].
In 2006, the World Health Organization (WHO) published guidelines for the management
of child TB that urged national TB control programs (NTPs) to (1) conduct contact investiga-
tions and offer IPT in child contacts <5 years and HIV-positive contacts of any age and (2)
screen symptomatic child contacts 5–14 years for TB disease [9–11]. Given the significant bur-
den of TB disease in young children, and the continued challenges in child TB diagnostics, suc-
cessful implementation of child contact management (CCM) is an important upstream
strategy to prevent TB in children. CCM is also an opportunity for early case detection and
treatment [12]. Many NTPs have adopted these guidelines; however, implementation in high
burden countries (HBCs) remains low with many countries experiencing operational chal-
lenges in CCM [13]. These challenges result in poor IPT initiation and completion rates.
CCM includes identifying, screening, and evaluating child contacts exposed to bacteriologi-
cally-positive TB, as well as initiating and completing either preventive therapy or appropriate
treatment for active TB. These CCM steps mirror the steps of the HIV care cascade steps,
which include identifying individuals at high risk, testing, initiating treatment, and retaining
individuals in care [14, 15]. A clear understanding of the steps at which individuals are lost
and the barriers that impact each step has helped to optimize HIV prevention strategies and is
the cornerstone of initiatives such as the 2013 HIV Care Continuum Initiative in the United
States [16]. A recent systematic review and meta-analysis by Alsdurf and colleagues proposed
the application of the HIV care framework to latent TB care for all ages to identify barriers and
improve steps in the latent TB care cascade [17]. The results demonstrated that individuals
were lost at every step of this cascade. Nevertheless, this review did not address the unique
challenges of preventing child TB in HBCs.
Child contact management cascade
In line with the first two pillars of the End TB Strategy that recommend: (1) integrated,
patient-centered TB care and prevention and (2) bold policies and supportive systems, we pro-
pose a CCM care cascade for child contacts <5 years who have been exposed to TB in the
household [18, 19]. Household definition varies among programs, however, a common defini-
tion used in country demographic health surveys and CCM programs is, ‘a person or group of
people, related or unrelated to each other, who live together in the same dwelling unit and
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share a common source of food [20, 21].’ Per WHO recommendations, the cascade starts with
the identification of all exposed child contacts aged<15 years. The first loss occurs if identifica-
tion of child contacts is incomplete. In the second step, all child contacts <5 years and symp-
tomatic or HIV-positive contacts 5–14 years undergo screening and evaluation to rule out
active TB. The second possible loss of child contacts occurs at this step. The third cascade step
includes IPT initiation, which only applies to child contacts <5 years or HIV-positive children.
We assume IPT eligibility for all child contacts who were screened and did not have TB dis-
ease. The final step in the cascade is IPT completion. The CCM cascade for child contacts for
preventive therapy, i.e., in child contacts <5 years is summarized in Fig 1.
For the first time, the 2016 WHO global tuberculosis report incorporated measures of
reported rates of IPT initiation in child contacts <5 years [1]. Only nine of 30 HBCs reported
data for this new indicator. From the data available, an estimated 7.1% of eligible child contacts
initiated IPT, far below the 90% target goal [1]. This further highlights the need to employ a
standardized care cascade to CCM to better understand the existing gaps and barriers, and
devise strategies to improve outcomes. Additionally, programmatic strategies and challenges
as well as perceptions from healthcare workers (HCWs) and family members regarding CCM
are important considerations to NTPs conducting CCM. We therefore conducted a mixed-
methods systematic review of evidence available from HBCs to (1) apply a care cascade to
CCM and report on child contact losses at each CCM cascade step; (2) summarize common
challenges, implementation gaps, and predictors of outcomes within CCM programs; and (3)
Fig 1. The child contact management cascade for preventive therapy.
https://doi.org/10.1371/journal.pone.0182185.g001
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identify CCM strategies implemented at each step in the cascade. The goal of this review is to
provide guidance to NTPs that are establishing or improving their CCM initiatives.
Materials and methods
Search strategy and selection criteria
We searched the electronic databases of PubMed/MEDLINE (NCBI), Scopus (Elsevier), and
Web of Science (Thomson Reuters) for studies published between January 1, 1996 and May
23, 2017. The search strategy was designed with a librarian (CC) to identify studies from HBCs
that describe or analyze CCM strategies throughout the CCM cascade steps (identification,
screening, IPT initiation, and IPT completion). This time period was selected so that we could
assess progress of CCM 10 years pre- and post-WHO 2006 CCM guidelines. For initial search
terms, we used the following free text and MeSH terms: tuberculosis, isoniazid preventive ther-
apy, contact management, child, and a list of countries with an estimated TB incidence of
greater than 40:100,000 population during 2015, to ensure inclusion of all countries listed on
the WHO TB, TB/HIV and MDR TB high burden lists [1]. The exact and detailed search strat-
egies, including related terms, are reported in S1 File. We followed the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to structure our sys-
tematic review preparation and reporting (S2 File) [22]. Details of the protocol for this system-
atic review were registered on PROSPERO: International prospective register of systematic
reviews (#CRD42016038105).
We included manuscripts describing countries with TB incidence >100:100,000 to capture
a homogenous set of countries and support more rigorous comparisons and program evalua-
tions. We therefore formulated a final search strategy to identify all available studies, published
in English that specifically targeted a) population: child contacts (<15 years) exposed to TB in
the household, from programmatic settings in HBCs, defined as TB incidence >100:100,000,
b) interventions: CCM strategies implemented within the CCM cascade, c) comparisons:
CCM strategies studied and compared in HBCs, and d) outcomes: monitoring and evaluation
of child contact outcomes reported in the literature for each CCM cascade step. We included
any quantitative (cohort, case control, cross sectional, ecological studies), qualitative, mixed-
methods study design except for randomized-controlled trials, editorials or commentaries. Ini-
tial search results were imported into EndNote, where duplicates were removed. Two authors
(DS, YHM) independently screened the titles and abstracts to determine each study’s initial
eligibility for inclusion. Disagreements between authors during screening were resolved
through discussion with the remaining authors. Five authors (DS, YHM, LDP, KDP, AMM)
divided the included studies and independently conducted full text review to determine each
study’s eligibility for final inclusion. Discrepancies about study eligibility were discussed and
resolved through consensus. Studies not meeting these criteria were excluded. Studies were
also excluded if they included only adult contacts, were non-human studies, were related solely
to drug resistant CCM, or involved IPT in HIV-positive children with no known TB exposure.
Given the heterogeneity of the studies conducted in programmatic settings, we could not con-
duct a meta-analysis.
Data extraction
Two authors (DS, YHM) performed the full data extraction. Data were extracted using a stan-
dardized data extraction tool created in Google Forms that was pre-piloted by authors. Data
auto filled into a Google worksheet that was exported into Microsoft Excel 2008. Data
extracted included article title, authors, year published, study year, journal title, study aims,
study design, methodology, phase of CCM addressed or reported (identification, screening,
Child contact management in high tuberculosis burden countries: A mixed-methods systematic review
PLOS ONE | https://doi.org/10.1371/journal.pone.0182185 August 1, 2017 4 / 23
IPT initiation, IPT completion), CCM challenges, CCM recommendations, and predictors for
the CCM cascade. We extracted both quantitative and qualitative data.
Quantitative data. Quantitative data was collected when available to highlight the child
contact losses at each step and calculate the proportion of child contacts completing each
CCM cascade step. Data included the number of index cases, child contacts <5 years identi-
fied, child contacts <5 years screened for TB disease, child contacts<5 years eligible for IPT,
child contacts <5 years initiating IPT, and child contacts <5 years completing IPT. We
defined child contacts screened as the number of child contacts who completed evaluation to
rule out active TB disease. Screening varied from simple symptom-based screening to proto-
cols that incorporate tuberculin skin testing, chest x-ray, and other diagnostic tests such as
evaluation of gastric aspirate. Child contact losses at this step were measured by subtracting
child contacts screened from those identified. The proportion of child contacts screened was
defined as the number of child contacts screened of those who were identified. IPT eligibility
was defined as child contacts who completed screening and did not have active TB disease. If
authors reported deferral reasons (e.g. previously treated with IPT, already treated for active
TB disease), these child contacts were not considered IPT eligible. Therefore, losses were mea-
sured by subtracting child contacts who initiated IPT from those who were screened and did
not have a deferral reason. The proportion of child contacts who initiated IPT was defined as
the number of child contacts who initiated IPT of those who were IPT eligible. In cases where
the number of child contacts eligible for IPT was not available, we used the number of child
contacts screened as the denominator for the IPT initiation rate. IPT completion losses were
measured by subtracting child contacts who completed IPT from those who initiated IPT. The
proportion of child contacts who completed IPT was defined as the number of child contacts
who completed at least 4/6 months of IPT of those who initiated IPT. Outcomes regarding pre-
dictors for completion of CCM cascade steps for contacts <15 years were also collected. Two
authors (DS, YHM) compiled the quantitative data and performed descriptive statistics using
Microsoft Excel.
Qualitative data. Qualitative data, including findings from in-depth interviews, focus
group discussions, and study authors’ observations, were systematically extracted. Data
included CCM interventions, CCM strategies, CCM challenges, and CCM recommendations as
described by authors, HCWs, or family members. Interventions, strategies, and challenges were
grouped into broad categories. Initial codes were independently generated from a review of
Assefa and colleagues [23] by two reviewers (DS and YHM) and cross-checked to enhance con-
sensus on primary codes. Reviewers (DS and YHM) then used an iterative process to further
refine and contextualize codes through constant and discursive comparative analysis [24, 25]
within and across studies to facilitate a comprehensive understanding of CCM challenges and
recommendations. Once concordance on codes was achieved, all studies were coded. Finally,
reviewers (DS, YHM, LDP, KDP, AMM) worked together to summarize the codes and finalize
seventeen sub-themes into seven meaningful themes that related to the review aims.
Results
Initial screening protocol
Our initial search was performed between January 1, 1996 and October 25, 2016 and was
updated to include articles through May 23, 2017. After removal of duplicate entries, 1919
studies were evaluated using titles and abstracts; 87 full text studies were reviewed for eligibility
and 36 studies were included in the systematic review. Hand searching by reviewing all refer-
ences of included studies yielded one additional study. In total, 37 studies were included in the
systematic review (Fig 2).
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Study characteristics
Table 1 summarizes characteristics of the 37 studies included in the review [21, 23, 26–60]. Of
37 studies, 22 studies were conducted in the African region, 14 in Southeast Asia, and one in
the Americas (Peru). The countries where most studies originated in the Africa region were
South Africa (n = 10), Ethiopia (n = 4), and Malawi (n = 3); and in the Southeast Asia region
were India (n = 5) and Indonesia (n = 4). Most studies were published in the last eight years
(2009–2017) with no studies published in the first five years (1997–2001) and only six studies
published in the five years between 2002 and 2006. Most studies (n = 25) conducted were
quantitative evaluations, three studies were qualitative and a growing number (n = 9) incorpo-
rated mixed methods. Of quantitative or mixed studies, 19 of 34 (56%) pulled data from pro-
gram settings and operational definitions throughout the CCM cascade varied greatly.
Fig 2. Study selection.
https://doi.org/10.1371/journal.pone.0182185.g002
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Child contact identification. Of the 34 studies that included quantitative data, 21
included the number of children identified. The sample size of child contacts <5 years identi-
fied in these 34 studies varied widely between 24 child contacts in a South African study [39]
and 1227 child contacts in a study from the Philippines [58].
TB screening. In 17 studies that included information regarding TB screening, rates var-
ied between a low of 2.7% of identified child contacts screened in a South African study [40]
and a high of 100% screened in a study from the Gambia [59]. In 41% (7/17) of studies, screen-
ing rates of<50% were reported (Fig 3).
IPT initiation. In 24 studies that included information regarding IPT initiation, rates var-
ied between a low of 2.3% initiation in a Kenyan study [35] and a high of 100% initiation in
studies from India [47] and Ethiopia [27]. In 38% (9/24) of studies, initiation rates of<50%
were reported (Fig 3).
IPT completion. In 17 studies, which included information regarding IPT completion,
rates varied between a completion rate of 0% in a South African study [40] to 94.5% comple-
tion in a study from the Gambia [59]. In 59% (10/17) of studies, completion rates of<50%
were reported. There was one study that measured adherence using a urine test, showing that
of those who completed IPT, 255/310 (82%) had good adherence [59] (Fig 3).
Child TB contact management challenges
A review of the 37 studies revealed many challenges present at every step of the CCM cascade.
We categorized these challenges into seven themes and seventeen sub-themes that are summa-
rized in Table 2 and described below.
Health system infrastructure. Health system infrastructure challenges could be divided
into three categories: lack of government and NTP prioritization, lack of tools to support docu-
mentation, management, and monitoring and evaluation (M&E) of CCM, and limited
resources. At the government level, lack of NTPs’ leadership to prioritize CCM implementa-
tion was reported (n = 6). Heavy demands to care for large numbers of TB cases, including
TB-HIV co-infection cases, were reported as reasons for poor performance of CCM strategies.
Additionally, at the clinic level, studies identified lack of tools to support documentation
Fig 3. Range of proportions of child contacts completing each CCM cascade step.
https://doi.org/10.1371/journal.pone.0182185.g003
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throughout CCM as a barrier (n = 13). This included lack of documents to record child con-
tacts as they move through every step of the CCM cascade. Although some programs reported
having a system or some tools in place for recording and reporting, these are not standardized
across facilities and insufficient for effective program monitoring and evaluation of CCM.
Finally, limited staff resources were identified as a barrier (n = 9). CCM increases HCW work-
load with additional monthly visits for child contacts. One study reported that prioritizing
index cases over child contacts was detrimental to CCM in a setting with limited staff [40].
Knowledge gaps. Challenges arising from inadequate knowledge of index cases, caregiv-
ers and HCWs were identified. Index cases and caregivers did not receive adequate health edu-
cation or did not comprehend information regarding CCM (n = 14). In particular, caregivers
were uninformed about the need for child contact screening and the importance of IPT. For
example, two studies reported that few index cases were informed about screening child con-
tacts (21% from Malawi, 32% from Zambia) [26, 56]. Several studies mentioned challenges
Table 2. Challenges and recommendations.
CHALLENGES RECOMMENDATIONS
Health System Infrastructure Health System Strengthening
Lack of government and NTP prioritization [21, 36, 40, 46, 51, 52] Introduce monitoring and evaluation tools [21, 23, 28, 35, 36, 38–40, 44, 47,
50, 55, 58, 60]
Lack of tools to support documentation [21, 23, 30, 31, 33, 35, 39–41, 44,
46, 50, 60]
Prioritize CCM and provide support to HCWs and clinics [26, 32, 33, 36, 37, 41,
42, 45–47, 51–53, 55–60]
Limited staff resources [30, 33, 40, 42, 48, 52, 53, 55, 58]
Knowledge Gaps Health Education
Index Case and caregiver education [23, 26, 33, 36, 44, 46, 48, 50, 51,
53, 55–57, 60]
Healthcare worker education [23, 26, 27, 30, 35, 36, 38, 40, 43, 44, 46–48, 50,
52, 53, 55–60]
Healthcare worker education regarding CCM [23, 26, 29–31, 33, 36, 37,
40, 44, 46–50, 53, 55–58, 60]
Index case and caregiver education [23, 27–29, 33, 34, 36, 38, 42, 44, 47, 49,
51–53, 56–59]
Knowledge regarding TB diagnosis [23, 31, 46, 47, 55, 58, 60]
Knowledge regarding INH resistance [57]
Improved Preventive Therapy
Attitudes and Perceptions Study efficacy and implement shorter regimens [33, 41, 47, 50, 53, 54]
Risk Perception* [23, 27–30, 33, 38, 42, 47–49, 51–53, 55, 57, 60] Synchronize IC and CC visits [42]
Patient-provider relationship [33, 58] Ensure availability of IPT [23, 27, 46, 60]
Create child friendly formulations [49, 54, 55, 57, 60]
Stigma
Stigma [21, 33, 34, 38, 55]
Access to Care
Cost, including transport, screening, diagnostic testing, and treatment
[23, 30, 35, 42, 45, 48, 49, 51–53, 58]
Travel time and coordination [23, 28, 43, 45, 47–49, 52, 55, 59]
Wait times and clinic schedule [23, 33, 42, 48, 53]
Competing Priorities
Family priorities [33, 42, 47, 48, 51, 52, 58, 59]
Treatment Related
Medication, including size, taste, duration of treatment [48–50, 53, 60]
Experienced side effects [47–49]
Ability to administer treatment to child contact [28, 33, 57, 59]
INH Procurement [23, 50, 58, 60]
CCM = Child TB Contact Management, IC = Index Case, CC = Child Contact, HCW = Healthcare Worker, NTP = National TB Program.
* Caregivers’ perceived low risk if child was healthy and asymptomatic.
https://doi.org/10.1371/journal.pone.0182185.t002
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with knowledge regarding IPT benefits and duration of therapy, which led to non-initiation
and non-adherence.
HCW knowledge gaps, lack of guidelines, and non-adherence to guidelines were found in
many studies (n = 21). An Indonesian healthcare worker said, “My understanding of IPT is
limited. There is no guideline for IPT available. I have no confidence to explain IPT to the
patient.”[53] Several studies mentioned that HCWs experienced challenges in ruling out TB
disease due to unavailability of tuberculin skin testing and/or chest x-ray, inability to interpret
these results, and overall lack of knowledge regarding the screening necessary to rule out TB
disease and initiation of IPT. One study reported that health center personnel were concerned
that IPT leads to INH resistance [57].
Attitudes and perceptions. Attitudes and perceptions about the need for screening and
IPT presented important challenges. Caregivers were reluctant to have child contacts screened
or initiated on IPT despite education regarding the importance of TB prevention (n = 17). The
most common reason was that child contacts were healthy and asymptomatic, and therefore
caregivers did not see a need for TB screening and/or IPT. An Indonesian caregiver said “I
wasn’t concentrating on that [IPT] because I thought [the child] was healthy anyway” [49].
Two studies noted that patient/provider relationship can also influence IPT adherence, with
negative relationships potentially hampering adherence [33, 58].
Stigma. Another important concern was stigma. Caregivers felt that child contact screen-
ing could lead to unwanted disclosure of TB and/or HIV to other family members and neigh-
bors (n = 5). As TB remains associated with HIV, IPT could be perceived as a marker of HIV
in addition to TB. A parent in a South African study stated “Most of people who have TB. . .feel
they would rather stay home because if they go to the clinic they will meet so and so who will
start gossiping about them. They will label me as HIV as I have seen done to others. In the end
children end up not getting treatment” [33].
Access to care. A major challenge identified by studies (n = 17) was the ability of caregiv-
ers and their child contacts to access care. This was found to be a challenge that affected every
CCM cascade step. Caregivers struggled to bring child contacts to the clinic for TB screening
and IPT provision. The most common challenge discussed was cost, including cost of trans-
port, screening, diagnostic testing, and medications (n = 1). A second major challenge was
transportation barriers, including long journey times to clinics and migration of child contacts
for reasons such as living with extended family (n = 10). Finally, long wait times and inconve-
nient clinic hours for working caregivers were reported in several studies as an access to care
barrier (n = 5); one study reported wait times of up to four hours [53].
Competing priorities. Another major barrier to child contact screening and adherence
reported was family prioritization of other competing needs over IPT (n = 8). Studies reported
a variety of such other priorities (i.e. parents’ work schedules, child contacts’ need to go to
school). Some studies reported that the relationship of the index case and the child contact
impacted the prioritization of CCM (n = 3). Specifically, non-parent index cases may not pass
information on to the primary caregivers and caregivers therefore may not bring child contacts
in for screening [45]. One study reported that index cases felt that if they were not directly tak-
ing care of their contacts, the children had a low risk of getting TB [52]. Finally, one study
reported that the death or nonadherence of the index case led to challenges to retain child con-
tacts in care [47].
Treatment-related challenges. Treatment-related issues were found to be important bar-
riers to adherence (n = 12). Size of pills, bitter taste, and long duration of treatment were
reported (n = 5), as were perceived medication side effects (n = 3). Administering isoniazid
(INH) to the child contact was a problem for some caregivers (n = 4); for example, one study
reported a concern that the parents may not see their children every day to be able to give
Child contact management in high tuberculosis burden countries: A mixed-methods systematic review
PLOS ONE | https://doi.org/10.1371/journal.pone.0182185 August 1, 2017 12 / 23
them their medication [33] or that they may forget to give the medication [28, 59]. Some stud-
ies reported that according to HCWs, procurement of INH may be a barrier to CCM (n = 4).
Child TB contact management recommendations
The 37 studies included in the review incorporated recommendations to improve CCM; these
recommendations were categorized into three themes that are summarized in Table 2 and
described below.
Health system strengthening. Most studies included health system strengthening recom-
mendations (n = 28). One major recommendation made in many studies, was to create and
introduce M&E tools for CCM (n = 14), which included separate child contact registers, IPT
cards, and IPT registers. Another recommendation was that NTPs need to prioritize CCM and
provide support to HCWs and TB clinics (n = 19). One study suggested quarterly supervisory
visits with routine measurement of how well CCM has been implemented [26]. Another study
suggested that HCWs coordinate with other agencies like daycare centres or schools to con-
duct screening of child contacts [58]. A third study included recommendations from nursing
staff who suggested applying a DOTs approach in the first few months of treatment to improve
caregiver adherence [33].
Health education. Many studies recommended health education for HCW’s (n = 22) as
well as index cases, caregivers, and the community (n = 19). Studies recommended that
HCW’s competence be improved through training, mentorship, program monitoring, and
supportive supervision. Specifically, it was recommended that HCWs be adequately trained
regarding the importance of contact screening so that they can effectively pass on this informa-
tion to the community. Furthermore, effective education and communication packages for
caregivers were seen as essential tools for HCWs to address caregiver concerns. On the care-
giver’s side, most studies suggested continuous health education with the family throughout
the six months of IPT. Targeted messages and educational materials to improve families’
awareness of child contact screening were recommended. Additionally, interventions should
address the perception that asymptomatic contacts do not need IPT and emphasize the impor-
tance of IPT completion. One study also recommended health education regarding infection
control so that further spread of TB can be prevented [52].
Improved preventive therapy. Fourteen studies recommended improving preventive
therapy delivery, which includes studying the efficacy and feasibility of implementing shorter
regimens (n = 6), ensuring availability of INH (n = 4), synchronizing index case and child con-
tact visits (n = 1), and creating child friendly formulations (n = 5).
Predictors of CCM cascade step completion
An analysis of predictors of successful CCM cascade step completion was included in eleven
studies. Predictors are summarized by CCM step in Table 3 and described below.
Screening. Predictors that were significantly associated with child contacts being brought
in for screening included: the index case was a parent, the index case was female, the child con-
tact lived near the TB clinic, the index case had a high perception of child contact susceptibility
to disease, the index case had a low perception of barriers to treatment, the index case had seri-
ous intention to bring the child in for screening, the child contact was identified at an urban
clinic rather than a rural clinic, the index case reported sharing a bedroom with any child<15
years, information regarding IPT was provided to the index case by a HCW, index case agreed
that IPT should be given to well children to prevent TB, and facility was non-governmental
rather than a local governmental unit [30, 45–47, 52, 56, 58].
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Table 3. Predictors of CCM cascade step completion.
Predictors to child contacts
completing each CCM step
Comments Child
Contact
Ages
Results Author Country
Screening
IC is female Female ICs more likely to bring child
contacts than male ICs
<5 years OR 2.67, p < 0.001 Nyirenda, M [30] Malawi
IC is parent Parents more likely to bring child contacts
than non-parents
<5 years OR 2.62, 95% CI 1.46–
4.7, p = 0.0013
Hall, C [45] Timor
Leste
Distance or location of TB
clinic
Screening at same district better than in
other district
<5 years OR 3.49, 95% CI 1.6–
7.66, p = 0.0017
Hall, C [45] Timor
Leste
Living near clinic better than far from clinic <15 years aOR 11.47, 95% CI 4.57–
28.79
Tornee, S [52] Thailand
Perception of susceptibility High perception of susceptibility to disease
better than low
<15 years aOR 2.90, 95% CI 1.18–
7.16
Tornee, S [52] Thailand
Perception of barriers Low perception of barriers better than high
perception
<15 years aOR 4.60, 95% CI 1.99–
10.60
Tornee, S [52] Thailand
Intention to bring CC to clinic Serious intentions better than non-serious
intentions
<15 years aOR 3.35, 95% CI 1.44–
7.76
Tornee, S [52] Thailand
Clinic Location Urban clinic better than rural clinic <6 years 72% vs 49%, p = 0.05 Rekha, B [47] India
<6 years RR 6.65, 95% CI 3.06–
14.42
Pothukuchi, M [46]* India
IC shares bedroom Shares bedroom with any child <15 years of
age
<5 years aOR 2.34, 95% CI 1.18–
4.40
Chabala, C [56] Zambia
HCW provided information Source of information regarding IPT was
from health care provider
<5 years aOR 3.22, 95% CI 1.11–
9.35
Chabala, C [56] Zambia
IPT Knowledge IC agreed that IPT should be provided to
well children to prevent TB
<5 years aOR 2.26, 95% CI 1.11–
4.60
Chabala, C [56] Zambia
Facility Type Non-governmental facility was better than
local government unit
<15 years 95.6% vs. 43.5% p<
0.001
Coprada, L [58] Philippines
IPT Initiation
IC is parent Parents more likely to initiate child contacts
than non-parents
<6 years 46% vs 19%, p = 0.001 Shivaramakrishna,
HR [50]
India
Parents more likely to initiate child contacts
than others
<6 years RR 1.4, 95% CI 1.0–2.0± Singh, AR [60] India
Home visit Initial home visit better than no home visit <6 years 41% vs 17%, p = 0.004 Shivaramakrishna,
HR [50]
India
IC shares bedroom Shares bedroom with any child <15 years of
age
<5 years aOR 4.56, 95% CI 1.53–
13.7
Chabala, C [56] Zambia
IPT Knowledge IC agreed that IPT should be provided to
well children to prevent TB
<5 years aOR 15.3, 95% CI 1.97–
118.9
Chabala, C [56] Zambia
Distance or location of TB
clinic
Child contacts living <5km from public health
institution more likely to initiate IPT
<6 years RR 1.4, 95% CI 1.1–1.6± Singh, AR [60] India
IPT Completion
Medication costs Lower medication costs better than higher <5 years OR 20, 95% CI 2.7–414.5 Rutherford, M [49] Indonesia
Transport costs Lower transport costs better than higher <5 years OR 3.3, 95% CI 1.1–10.2 Rutherford, M [49] Indonesia
Treatment duration Shorter treatment (3HR) better than longer
treatment (6H)
<5 years 67% vs 27%, OR 4.97,
95% CI 2.4–10.36, p<
0.001
Van Zyl, S [41] South
Africa
Supervision Supervision by HCW or community
supporter is better than supervision by
caregiver/index case
<5 years OR 4.43, 95% CI 1.47–
13.72, p = 0.006
Van Zyl, S [41] South
Africa
(Continued )
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IPT initiation. Predictors that were significantly associated with child contacts initiating
IPT included: the index case was a parent, child contact had a home visit, index case reported
sharing a bedroom with any child<15 years, index case agreed that IPT should be given to
well children to prevent TB, and distance <5km from the public health institution [50, 56, 60].
IPT completion. Predictors that were significantly associated with IPT completion
included: low medication costs, low transport costs, shorter regimen, directly observed therapy
by HCW or community supporter, and initiating therapy at a rural site [41, 47, 49].
Discussion
This is the first systematic review to examine the CCM cascade in HBCs with the goal of pro-
viding guidance to NTPs that are establishing or improving CCM. We used mixed-methods to
report child contact losses at each CCM cascade step, to identify CCM strategies implemented
in HBCs, and to summarize common challenges and positive predictors of CCM outcomes.
We found many losses at each CCM cascade step, with variability in the definitions that pro-
grams used throughout the CCM cascade. Additionally, we found great variation in the rates
of TB identification, screening, IPT initiation, and IPT completion. While a few studies
reported high IPT initiation and completion rates, most programs struggled with suboptimal
CCM.
The first WHO guidelines to recommend CCM were published in 2006. Therefore, not sur-
prisingly, most studies included in the review were published in the last eight years despite
searching since 1996. This likely represents an important shift in CCM after publication of the
WHO guidelines with more countries realizing the potential impact of CCM to prevent TB
amongst the young and vulnerable. Interestingly, almost a third of studies (10/37) were from
South Africa, reporting the highest TB incidence in the world in 2015 [1].
We used the HIV care cascade as a model for the CCM cascade, which provided a frame-
work to separate the primary and secondary drivers impacting each of the four cascade steps.
Ultimately, the aim for CCM in HBCs is to (1) identify all child contacts exposed to a bacterio-
logically confirmed TB case, (2) screen all identified child contacts for active TB disease, (3)
ensure that all eligible screened contacts either initiate treatment for active TB or IPT, and (4)
support treatment completion. Applying the HIV care cascade to TB infection has been suc-
cessfully utilized by other researchers in a broader population [17]. Based on our results, we
compiled a driver diagram (Fig 4) to provide further guidance to NTPs and the research com-
munity on improving CCM. The challenges and predictors identified translate into the pri-
mary drivers that need to be addressed to achieve successful CCM. These include: health
system infrastructure, knowledge gaps, attitudes and perceptions regarding CCM, stigma,
access to care, competing priorities, index case characteristics, and treatment related
challenges.
Table 3. (Continued)
Predictors to child contacts
completing each CCM step
Comments Child
Contact
Ages
Results Author Country
Clinic location Rural clinic better than urban clinic <6 years 95% vs 61%, p< 0.01 Rekha, B [47] India
*Screening and IPT initiation were analyzed together.
±Relative risk was calculated with variables “distance > 5km vs. 5-10km” and “child lives with other individual vs. parent” and outcome “not initiating IPT.”
CCM = Child TB Contact Management, IC = Index Case, CC = Child Contact, HCW = Healthcare Worker, OR = Odds Ratio, CI = Confidence Interval,
aOR = Adjusted Odds Ratio, RR = Relative Risk.
https://doi.org/10.1371/journal.pone.0182185.t003
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Health system infrastructure was identified as a primary driver that impacts all four steps in
the CCM cascade. The secondary drivers for health system infrastructure include government
and NTP prioritization of CCM, limited staff resources, and lack of documentation of all steps,
facility type (urban vs. rural, NGO vs. government), and type of HCW conducting CCM edu-
cation. With the recent requirement by the WHO to report IPT initiation in child contacts <5
years, political will to implement and improve CCM will likely increase from the ministry
level. Prioritization of CCM by NTPs has the greatest potential impact, as this driver will ulti-
mately influence all other primary and secondary drivers.
An important aspect of CCM prioritization by NTPs will be selecting implementation or
intervention strategies to optimize all CCM cascade steps. Both passive and active approaches
to CCM have been reported. Passive approaches include methods such as HCWs verbally
inviting index cases to bring child contacts for screening without follow up when contacts are
not brought in. Some studies included in our review incorporated active CCM strategies such
as the implementation of: home visits for identification and screening, M&E tools that docu-
ment all steps of CCM (clinic-based), and medication administration (community-based). It is
unclear which of these strategies are most effective, and further research to compare effective-
ness of different CCM approaches (e.g. clinic-based vs community-based) as well as cost analy-
ses are needed.
Fig 4. Driver diagram for child contact management.
https://doi.org/10.1371/journal.pone.0182185.g004
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Although frequently recommended, standard M&E tools for CCM are generally lacking.
Most studies that recommended M&E focused on IPT initiation and completion tools. Several
studies that incorporated active strategies to track child contacts reported improved identifica-
tion rates as well as high screening rates after implementation of an IPT register. A WHO rec-
ommended standardized CCM register that incorporates all four CCM cascade steps would
likely be an effective and efficient tool. Tools should also incorporate INH supply tracking to
prompt medication ordering and prevent clinic stock-outs. With the new WHO IPT reporting
requirement, standardized tools may assist NTPs in reporting this outcome.
Another primary driver impacting all four CCM steps is knowledge gaps of HCWs as well
as index cases and caregivers. Providing CCM support to clinics from the ministry level in
order to incorporate standardized education for HCWs is an important component that could
also result in improved health education provided to index cases and caregivers. Health educa-
tion strategies should ideally be longitudinal, available on demand, and practice-based in
order to provide ongoing CCM support. With rapid technological advances and widespread
mobile networks in HBCs, using mobile messaging programs such as WhatsApp Messenger
[43] or utilizing videoconferencing like the ECHO model [61] could enable NTPs to provide
continuous education to rural areas at minimal cost.
Several studies reported the inability of HCWs to rule out active TB disease during the
CCM screening step when TSTs and x-rays are lacking in clinics. In 24 studies in this system-
atic review that reported data on IPT initiation in child contacts screened, 9 (38%) reported
that fewer than 50% of child contacts screened were initiated on IPT. There are two main pro-
grammatic scenarios during which children may get lost in the screening to IPT initiation cas-
cade step: (1) Children who screen positive on the symptom-based screening and are referred
to higher levels of care for additional diagnostics, and (2) All child contacts (including asymp-
tomatic) who reside in a country where NTP guidelines require tests such as x-ray or TST
prior to initiating IPT and these tests are unavailable at the community level therefore prompt-
ing referral to higher level facilities.
Diagnosing TB and obtaining bacteriologic confirmation in children remains a challenge
globally which further complicates CCM. The difference between the difficult task of obtaining
bacteriologic confirmation in a child with presumptive TB disease and ruling out TB disease in
an asymptomatic child contact to initiate IPT should not be confused with one another. A
symptom-based screening approach to rule out TB disease in child contacts and initiate IPT is
recommended by the WHO [9, 11]. As demonstrated by Triasih and colleagues [54], symp-
tom-based screening is a simple and safe screening method, and special investigations for
identifying or excluding TB disease can be reserved for symptomatic children [62]. Children
who screen symptomatic on symptom-based screening, and are then referred to higher levels
of care for TB diagnostics are at great risk of being lost, particularly those in whom TB disease
is excluded and are told to return to the community level for IPT initiation. Implementing a
symptom-based screening approach, incorporating HCW education to reinforce the adequacy
of symptom-based screening to rule out active TB for CCM [54], and improving communica-
tion between community and higher level facilities are key steps in decreasing the losses
between screening to rule out TB disease and IPT initiation.
In addition to improving HCW education regarding screening, there are knowledge gaps
regarding INH resistance. One study suggested that IPT initiation may be hindered by HCW
concerns that IPT can result in the development of INH-resistant TB [59]. Although not
reported in other studies included in this review, in our experience, this is a concern that is fre-
quently discussed among HCWs working in CCM. There is no evidence that IPT will result in
the development of resistance in children, therefore, this also highlights the need for evidence
based education of HCWs by NTPs [63].
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Attitudes and perceptions about CCM constitute a primary driver that impacts the entire
cascade. Despite receiving health education, index cases and caregivers in many studies were
reluctant to bring their child contacts for screening or initiate IPT as they felt that they were
healthy and asymptomatic. In many cultures, people do not endorse preventive treatments
and there is a misperception that they do not need to take medicines when not feeling sick.
Some of the attitudes and perceptions about CCM may also be closely intertwined and per-
petuate another primary driver–stigma. CCM stigma is likely linked with historic TB stigma as
well as HIV stigma in settings with high TB-HIV co-infection rates. Index cases may not have
disclosed their TB status to families so bringing child contacts in for screening could poten-
tially risk disclosure. Furthermore, HCWs who live in the same communities as patients may
sympathize with patients regarding TB disclosure–their efforts to protect them may actually
hinder CCM activities. Although not found in our systematic review, we suspect that HCW
stigma regarding CCM may be a secondary driver influencing all cascade steps. Continued
sensitization of HCWs and communities through population based health education/TB cam-
paigns would likely increase knowledge, reduce stigma, and change attitudes and perceptions
regarding CCM.
Access to care, competing priorities, and index case characteristics are drivers that impact
screening, IPT initiation, and IPT completion. Secondary drivers such as transport cost and
clinic wait times could ideally be prioritized from the ministry level downward. Solutions may
include decentralizing and expanding CCM capacity such as offering active CCM strategies,
decreasing costs for CCM, and increasing staff and clinic capacity to decrease wait times. Com-
peting priorities such as conflicting caregiver and child contact schedules and index case char-
acteristics may be harder to address but could be reduced by enhancing patient-centered care
in TB facilities and allowing the caregivers of children to be involved in creating a more flexible
care-plan for their situation.
Most HBCs are also low-resource settings where families struggle financially and often face
catastropic costs due to TB, especially if the caregiver is co-infected with HIV [19]. Hence, eco-
nomic barriers often prevent caregivers from bringing child contacts to the clinic or initiating
IPT. Strategies that minimize costs while affording flexibility to caregivers will likely make it
easier for families to access and complete IPT. Possible solutions include: investing more time
in family discussions to devise a family centered plan before IPT initiation, identifying some-
one else to bring the child for follow-up visits if the primary caregiver is not available, or shift-
ing to community-based delivery of IPT. Index case characteristics such as gender,
relationship to child contact, and index case knowledge regarding IPT are important predic-
tors that warrant further study to identify child contacts needing additional support.
Treatment-related challenges including regimen duration; pill size and taste; medication
collection; administration and supervision; medication costs; and INH procurement, consti-
tute a primary driver that impacts IPT initiation and completion. Recently, shorter regimens
such as three months of a once-weekly combination of rifapentine and isoniazid have been
shown to be safe and effective in children [64]. Implementing shorter regimens would likely
improve adherence. Child-friendly fixed dose combinations that are dissolvable and taste good
have been available for active TB treatment as of 2016 [65, 66]. Similar formulations for pre-
ventive therapy are needed and will likely be better tolerated. Synchronizing follow up visits
for the child contact and the index case is a strategy to consider for improving treatment com-
pletion. As Egere and colleagues demonstrated, incorporating urine testing for adherence may
help programs evaluate their medication monitoring strategies [59]. Finally, ensuring a reliable
supply of INH is essential as drug shortages disrupt IPT.
Our review demonstrates that there are many factors related to the successful delivery of
preventive therapy among child household contacts, however, the broad structure to support
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effective and comprehensive CCM is often lacking in HBCs. Pillar one in the End TB Strategy
urges us to put patients at the heart of service delivery and create an integrated, patient-cen-
tered care and prevention approach [18, 19]. This requires a robust paradigm shift toward pre-
vention and family-based TB care in order to promote more equitable distribution of resource
allocation and support the creation of a CCM friendly healthcare environment. From our
review, we recommend that a standardized guideline for an effective CCM strategy should
include the following: (1) active strategy to identify contacts at risk, (2) structure, processes
and tools in facilities and community to implement, track, and monitor CCM, (3) ongoing
training and education for HCWs tasked with implementing CCM, (4) tools and strategies to
educate caregivers, index patients and the community as a whole, and (5) research toward
improved, shorter and child-friendly preventive therapy treatment regimens. Using this struc-
ture, programs can perform additional qualitative research and customize interventions to
address CCM barriers in ways that are context specific and appropriate.
Our review has several limitations. Most studies did not uniformly report on the CCM cas-
cade steps making it difficult to compare the losses at different CCM steps between studies.
For example, some studies reported the number of index cases bringing child contacts for
screening rather than the number of child contacts screened. It was not possible to incorporate
these results in our review since index cases may have brought in multiple children <5 years
for screening. However, standardization of CCM reporting seems to be improving in more
recent studies. Nonetheless, the heterogeneity of study designs employed to examine contact
tracing limited our ability to conduct a meta-analysis and calculate summary estimates. Sec-
ond, we noted inconsistencies in CCM definitions. There was an inconsistency between
reporting child contacts <5 years versus<6 years; seven of 37 studies reported data for child
contacts aged<6 years. With the recent requirement by the WHO to report IPT initiation out-
comes in child contacts<5 years, we anticipate future uniformity that will allow for better
quantitative analysis of the CCM cascade. Studies did not always report their definition of a
household. Household definition determines the pool of identified child contacts who will be
tracked throughout the CCM cascade. Further research to study and standardize this defini-
tion is needed and we encourage investigators to include their household definitions in future
literature. Similarly, the definition of IPT eligibility varies and we encourage programs to look
closely at IPT deferment reasons. Many deferred child contacts are also missed opportunities
between the screening and IPT initiation phase. Third, given the programmatic nature of
CCM, it is likely that work was presented at conferences but has not been published in the lit-
erature. We did not include conference proceedings or other grey literature in the review,
which could have caused a publication bias. Finally, the challenges and recommendations in
our review are a compilation of qualitative data as well as authors’ observations and program-
matic experiences. The latter have not been formally studied and more research is needed to
improve global generalizability.
Conclusions
Despite a decade-long recommendation to conduct CCM in HBCs, many child contacts are
still lost at each step of the CCM cascade. Our review reveals that HBCs experience similar
challenges and implementation gaps globally in conducting CCM. Prioritization of a CCM
friendly healthcare environment is imperative and should include structure, processes and
tools to implement and monitor CCM; health education interventions for HCWs, caregivers,
index cases and the community; and active, evidence-based strategies to eliminate barriers. A
focused approach toward every aspect of the CCM cascade will likely diminish losses through-
out the CCM cascade and ultimately decrease TB related morbidity and mortality in children.
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